anti- WDR32 antibody
Background:
WDR32, containing seven WD repeats, is also termed DDB1-and CUL4-associated factor 10(DCAF10), which may function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex(PMID: 16949367). WDR32 is able to interact with DDB1(PMID: 16949367). WDR32 is supposed to be implicated in process of ubiquitin-dependent protein degradation system. Two isoforms are described and produced by alternative splicing. This WDR32 antibody majorly detects WDR32 isoform1 with a theoretical MW of 61 kDa.
Clonality:
polyclonal
Classification:
Primary antibody
Alternative names:
DCAF10, FLJ23201, WD repeat domain 32, WDR32
Specificity:
Human, Mouse, Rat
Host:
Rabbit
Isotype:
IgG
Immunogen:
WD repeat domain 32
Purification:
Immunogen affinity purified
Purity:
≥95% as determined by SDS-PAGE
Calculated molecular weight:
102 kDa
Form:
liquid
Applications:
ELISA, IHC, IP, WB, IF
Recommended dilution:
WB: 1:200-1:2000; IP: 1:200-1:1000; IF: 1:20-1:200; IHC: 1:20-1:200
Storage:
PBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
More info:
Email: info@sobekbio.com
Orders:
Email: orders@sobekbio.com
Fine Biotech is an ISO9001:2008 Certified Company,offers a full line of quality research kits,which include ELISA Kits,related ELISA assistant reagents and more high quality antibodies, recombinant proteins. Fine Biotech technical support are delicated to providing with professional and friendly assistance for our customers. Strict and multiple quality control ensure that our products continue to successfully supply for the international market. Moreover, we strive to continuously improve the customer experience through comprehensive technical support. High quality,rapid turnaround and personal support for all FineTest services are guaranteed. Should you have any problems,or any ideas on ways that we can improve our service,please feel free to call upon us.Thank you for your interest in FineTest products and we look forward to supplying you in the near future.